FDA Approves Brexanolone (Zulresso), First Drug for Postpartum Depression - Medscape

FDA Approves Brexanolone (Zulresso), First Drug for Postpartum Depression  MedscapeThe US Food and Drug Administration (FDA) has approved brexanolone intravenous infusion (Zulresso, Sage Therapeutics), the first-ever drug indicated for the ...